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Background: This study examines the effect of graduated hyperglycaemia on the
state and oxygen-binding ability of hemoglobin, the correlation of phospholipid fractions
and their metabolites in the membrane, the activity of proteolytic enzymes and the
morphofunctional state of erythrocytes.
Methods: Conformational changes in the molecule of hemoglobin were
determined by Raman spectroscopy. The structure of the erythrocytes was
analyzed using laser interference microscopy (LIM). To determine the activity of
NADN-methemoglobinreductase, we used the P.G. Board method. The degree of
glycosylation of the erythrocyte membranes was determined using a method previously
described by Felkoren et al. Lipid extraction was performed using the Bligh and Dyer
method. Detection of the phospholipids was performed using V. E. Vaskovsky method.
Results: Conditions of hyperglycaemia are characterized by a low affinity of hemoglobin
to oxygen, which is manifested as a parallel decrease in the content of hemoglobin
oxyform and the growth of deoxyform, methemoglobin and membrane-bound
hemoglobin. The degree of glycosylation of membrane proteins and hemoglobin is
high. For example, in the case of hyperglycaemia, erythrocytic membranes reduce the
content of all phospholipid fractions with a simultaneous increase in lysoforms, free fatty
acids and the diacylglycerol (DAG). Step wise hyperglycaemia in incubation medium and
human erythrocytes results in an increased content of peptide components and general
trypsin-like activity in the cytosol, with a simultaneous decreased activity of µ-calpain
and caspase 3.
Conclusions: Metabolic disorders and damage of cell membranes during
hyperglycaemia cause an increase in the population of echinocytes and spherocytes. The
resulting disorders are accompanied with a high probability of intravascular haemolysis.
Keywords: human erythrocytes, hyperglycaemia, hemoglobin system, membrane lipids, proteolytic activity
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INTRODUCTION
Various physiological, pathological and nutritional conditions
such as physical activity, large amounts of sweet food, emotional
stress, metabolic syndrome, and diabetes are accompanied by
high level of glucose in blood plasma. The high content of
glucose in plasma accelerates the probability of non-enzymatic
glycosylation of proteins, which induce damage to the cell
membrane due to nonspecific aggregation of protein molecules
and changes in protein-protein and protein-lipid interactions
(Vasilyeva, 2005).
Taken together, these changes initiate the rapid aging of
cells and the human organism. Metabolic syndrome significantly
accelerates the development of atherosclerotic vascular damage
and provokes earlier disability and death. During metabolic
syndrome, which is currently the most common pathology of
metabolic disorders, glycosylation of erythrocytic membrane
proteins induces the impairment of rheological parameters of
blood, low deformability and mobility of erythrocytes, high
aggregation of erythrocytes and thrombocytes, high blood
viscosity, and arterial hypertension (Shilov et al., 2008).
In addition, glycosylation of erythrocytic membrane proteins
and hemoglobin during hyperglycaemia increases adhesion to
endothelial cells, resulting in membrane destabilization (change
in the asymmetry of membrane phospholipids), changes in
viscoelastic properties of cells and their morphology (Riquelme
et al., 2005). Taken together, these changes can impair the oxygen-
transport function of erythrocytes and reduce erythrocyte
lifespan. Furthermore, the number of damaged circulating
cells and, aging erythrocytes will increase (Lang et al., 2006;
Mindukshev et al., 2010).
The biochemical mechanisms of impaired growth in human
erythrocytes during the development of hyperglycaemia have
not been sufficiently investigated. In particular, there are scarce
data on the composition and status of the lipid phase of
the membranes, the relationship of these processes with the
activity ofmethemoglobin formation and the activity of apoptotic
enzymes. Moreover, there is a lack of data in the literature on
the effect of these processes on the morphofunctional state of
erythrocytes and their oxygen-transport properties.
Therefore, we aimed to perform a comprehensive study of
the effects of graduated hyperglycaemia on the composition
TABLE 1 | Correlation of hemoglobin formation (%), content of glycosylated hemoglobin (g/l) and the degree of glycosylation of membrane proteins (rel. units).
Index Degree of hyperglycemia, mM/l
5 10 15 20
DesoxyHb, % 39.320 ± 0.337 39.927 ± 0.295 40.841 ± 0.321*1 40.470 ± 0.123*
OxyHb, % 58.359 ± 0.230 57.676 ± 0.356* 56.280 ± 0.286*1 56.779 ± 0.251*
MetHb, % 2.321 ± 0.022 2.397 ± 0.023* 2.899 ± 0.042*1 2.751 ± 0.033*
Membrane-boundHb, % 8.172 ± 0.259 10.430 ± 0.448* 12.100 ± 0.994*1 15.888 ± 0.427*1
GlycatedHb, Ŵ/π 6.220 ± 0.221 6.667 ± 0.448 7.083 ± 0.083 10.833 ± 0.397*1
Degree of glycosylation of membrane proteins, rel.units. 0.109 ± 0.002 0.182 ± 0.007* 0.206 ± 0.008* 0.304 ± 0.019*
*P< 0.05 as related to normoglycemia;
∆P < 0.05 as related to previous degree of hyperglycemia.
of phospholipids, the activity of proteolytic enzymes, and, the
consequent effect of ongoing processes on the morphofunctional
state of erythrocytes and the oxygen-transport properties of
hemoglobin.
MATERIALS AND METHODS
Blood Samples
This study was performed using pure erythrocyte fractions
isolated from freshly obtained, anticoagulated donor blood
from the regional station of blood transfusion. The average
age of the donors was 28.4 ± 1.7 years. The research was
approved by the Local Ethics Board at Mordovia State University
in accordance with the principles of Good Clinical Practice
(protocol number 12 of 17 September 2014). Informed consent
statements were signed by all donors participating in the
experiment.
Erythrocytes were washed 4 times with PBS until pure
fractions were formed and centrifuged at 600 g for 10 min
at temperature +4◦C. Incubation of the erythrocytes was
performed in a Ringer’s solution at a ratio of 2:1 at 37◦C for
30min with gentle mixing every 5min (to avoid haemolysis).
For incubation, a Ringer’s solution was used containing
as follow (in mM/l): NaCl–136.75; KCl–to 2.68; NaHCO3–
11.9 per; Na2HPO4–0.342; MgCl2–0.105; CaCl2–1.8, glucose–5
(normoglycaemia).
Hyperglycemia Model
Hyperglycaemic conditions were characterized by glucose
content, in which the graduated concentration was accompanied
by an equimolar decrease in the content of sodium chloride:
10 mM/l glucose–NaCl: 131.75 mM/l; 15 mM/l glucose–NaCl:
126.75 mm/l; 20 mM/l NaCl; 121.75 mM/L. The incubation
mediumwas separated by centrifugation in the samemanner, and
erythrocytes were analyzed using spectrophotometry (Zavodnik
and Lapshina, 1996) to determine the correlation of the
hemoglobin forms.
Conformation and Properties of
Hemoglobin
Conformational changes in the hemoglobin molecule were
determined by Raman scattering on In Via Renishaw (UK)
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microscope with a short-focus high-luminosity monochromator
(focus distance–250 mm).
For excitation of the Raman spectra we used a laser with a
wavelength of 532 nm, max radiation power of 100 mW, and
100 × objective. The data recorder was a –CCD detector (1,024
× 256 pixels with Peltier cooling to −70◦C) with a grating of
1800 lines/mm. The digitized spectra were processed in WIRE
3.3 (part of the unit’s software). To analyse the conformation
of globin haematoporphyrin, we used specific bands of the RS
spectrum, which enabled an estimate of the relative amount of
oxyhemoglobin and the ability of hemoglobin to bind to and
isolate ligands, including oxygen (Brazhe et al., 2009).
Laser Interference Microscopy
The structure of the erythrocytes was analyzed using laser
interference microscopy (LIM) in vitro (Byazhe et al., 2006;
Yusipovich et al., 2011; Revin et al., 2016) using MII-4
sysytem (Russia). The measurements were performed at room
temperature, and a suspension of erythrocytes in the incubation
medium (1:2) was placed on mirror glass. The smear was
prepared and covered with cover glass. Images of 10 sites, with a
monolayer arrangement of cells in an interference channel, were
obtained, with reflected light in each sample. The images were
processed using FIJI (Schindelin et al., 2012). The structure of the
erythrocytes was assessed by registering the average value of the
optical path difference (OPD) and phase image area using at least
100 cells from each sample. The phase volume of the erythrocyte
was calculated using the following formula:
Vcell = Fmean · S/ncell − nm
Where Fmean is the mean value of the optical path difference,
proportional to the thickness of erythrocyte; S is the phase image
area of the cells; ncell is the refractive index of erythrocyte, equal
to 1.405; nm is the refractive index of the surrounding solution
(1.333).
Determination of the Activity of
NADN-Methemoglobinreductase
To determine the activity of NADN-methemoglobinreductase,
we used the P.G. Board method (Board, 1981). The degree
of glycosylation of the erythrocyte membranes was determined
using a method previously described by Felkoren et al. (1991).
Before defining the proteolytic enzymes, the suspension of
erythrocytes was haemolysed by the addition of a buffer of 20mM
three-HCl containing 2 mM EDTA, pH 7.5 in a ratio of 1:9. The
haemolysate was maintained at a temperature 2-4◦C for 15 min
and centrifuged at 16,000× g for 40 min.
The supernatant was used to determine the activity of
µ-calpain with the release of enzyme using ion exchange
chromatography (column 3× 15; DEAE-cellulose) and eluted by
a gradient of 0.1–0.4 M NaCl. Next, the mean calpain activity
of the fractions was determined using incubation medium
previously described by Sorimachi et al. (1997) (imidasole buffer,
4% casein, 50 mM of CaCl2, 50 mM of cysteine) (Stroev et al.,
1991; Elce John, 2000; Sorimachi et al., 2000). Then, the general
proteolytic activity, in ascending order of the absorption level at a
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TABLE 3 | Phospholipid composition of erythrocytic membranes under normoglycaemia and graduated hyperglycaemia.
Phospholipid N ◦ of peak Rf 5 10 15 20
mkgP/mg of lipid
LPC 1 0.13 0.058 ± 0.003 0.023 ± 0.001 0.078 ± 0.004* 0.093 ± 0.005*
SM 2 0.21 0.808 ± 0.040 0.471 ± 0.024* 0.678 ± 0.034* 0.348 ± 0.017*
PC 3 0.34 0.346 ± 0.017 0.147 ± 0.007* 0.252 ± 0.013*◦ 0.107 ± 0.005*◦
PI+PS 4 0.58 1.239 ± 0.062 0.632 ± 0.032 1.017 ± 0.051* 0.527 ± 0.026*
PEA 5 0.9 0.768 ± 0.038 0.359 ± 0.018* 0.608 ± 0.03◦ 0.185 ± 0.009*
PC/PEA 0.45 0.41 0.41 0.59
*P< 0.01 as related to normoglycemia;
◦P< 0.01 as related to previous level.
TABLE 4 | Content of free fatty acids (FFA) and DAG, in mcg FA/mg of total lipids.
Index Degree of hyperglycemia
5 mM/l (norm) 10 mm/l 15 mM/l 20 mM/l
FFA 15.0 ± 0.7 28.0 ± 0.9* 31.0 ± 1.3* 35. 0 ± 1.5*◦
DAG 11.0 ± 0.6 17.0 ± 0.8* 20.0 ± 1.1* 31.0 ± 1.4*◦
*P < 0.01 as related to normoglycemia;
◦P < 0.01 as related to the level of 10 mM/l.
wavelength of 280 nm, was measured following incubation of the
haemolysate and protein deposition by 5% trichloroacetic acid
(TCA) (Bazarnova et al., 2008).
The release of fractions with calpain activity occurred during
movement in a reverse gradient from 0.2 to 0.1 M of sodium
chloride immediately after the release of hemoglobin. The
activity of µ-calpain was calculated as the difference between
activity with and without the inhibitor in the incubation
medium (phenylmetylsulfonylfluoride, 2 mM PMSF, Sigma,
USA). The content of peptides in the incubation medium and
erythrocytes was determined using the Lowry method, with the
Bio-Rad DC Protein Assay a set of protein assay Dc reagents
(Bio-Rad). The content of peptides in the erythrocytes was
determined after deproteinisation by 5% of TCA. The active
concentration of caspase-3 in erythrocytes was recorded using an
enzyme immunoassay (BD Biosciences, USA) with Stat Fax 3200
microplate reader (USA).
Analysis of Membrane Phospholipids
To analyse the state of the membrane phospholipids, we isolated
membranes from the haemolysate using 5 mM NaH2PO4+
0.5 mM PMSF (phenylmetylsulfonylfluoride) solution, cooled to
0◦C, pH 8.0 in a ratio of 1:20. The mixture was incubated for 10
min at 4◦C and then centrifuged at 20,000 × g for 40 min (0◦C).
The supernatant was removed and the residue was resuspended
in lysis solution and centrifuged in the same manner. The sample
was washed three times. Lipid extraction was performed using the
Bligh and Dyer method (Bligh and Dyer, 1959).
To separate the phospholipid fractions we used one-
dimensional chromatography combined with chloroform/
TABLE 5 | Content of protein and peptide compounds in the incubation medium
and peptides in erythrocytes (during normo- and hyperglycaemia).
Indicators Content of glucose in incubation media. mM/l
5 10 15 20
Content of proteins and
peptides in incubation
media. µm/ml
71.6 ± 4.8 84.3 ± 5.3 114.9 ± 5.7* 101.7 ± 5.1*
Content of peptides in
erythrocyte. µg/ml
106.5 ± 6.6 189.9 ± 6.3* 160.9 ± 5.9* 125.4 ± 6.2◦
*P< 0.01 as related to normoglycemia;
◦P< 0.05 as related to normoglycemia.
methanol/glacial acetic acid/water in a ratio of 60/50/1/4
(Evans et al., 1990). Chromatographic separation was
performed in a thin layer of silica gel deposited on a glass
plate. Standard plates from HPTLC Silicagel 60 F254 (Merck.
Germany) were used. To separate DAG and FFA we used
the combination of heptane/diethyl ether/glacial acetic acid
(60/40/2 by volume). Detection of the phospholipids was
performed using V. E. Vaskovsky method (Vaskovsky et al.,
1975).
The amount of phospholipid fractions and free fatty
acids in the erythrocytic membranes was determined using
a densitometer TCL Scanner 3 (Gamag, Switzerland) at an
absorption wavelength of 360 nm using a deuterium lamp and
winCATC software.
Statistical Analysis
The statistical processing was performed using the Statistika
0.06 software package. To determine the significance levels, the
Student’s test was used. Repeats in the variation series of different
indicators were from 8 to 20 values.
RESULTS
Hyperglycaemic conditions are characterized by a low affinity
of hemoglobin to oxygen, which is manifested as a parallel
decrease in the content of hemoglobin oxyform and the growth
of desoxyform (Table 1).
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TABLE 6 | Activity of erythrocyte enzymes during graduated hyperglycaemia.
Enzyme activity Concentration of glucose in incubation media, mM/l
5 10 15 20
NADH-methemoglobinreductase, µM/min · gHb 19.545 ± 3.801 14.760 ± 3.878* 27.858 ± 2.446* 20.685 ± 5.019
µ-Calpain, µM/Min · mg of protein 15.414 ± 2.317 11.979 ± 1.398 11.593 ± 1.489 9.130 ± 1.402*
Caspase-3 activity, ng/ml 0.562 ± 0.029 0.443 ± 0.035* 0.401 ± 0.027* 0.345 ± 0.025*◦
Trypsin-like activity, membrane fraction, µg/ml·h 0.159 ± 0.079 0.135 ± 0.075 0.151 ± 0.072 0.171 ± 0.079
Trypsin-like activity, cytosol, µg/ml·h 2.15 ± 0.025 2.70 ± 0.015* 3.29 ± 0.041*◦ 3.48 ± 0.030*◦
*P < 0.01 as related to normoglycemia;
◦P < 0.05 as related to normoglycemia.
TABLE 7 | Morphological parameters of erythrocytes in normo- and hyperglycaemia, according to LIM results.
Phase area of
erythrocyte, S, µm2
Mean phase height,
8mean, nm
Phase volume of
erythrocyte, V, µm3
Physical (geometrical)
width of erythrocyte,
Zmean, µm
Hemoglobin weight
in erythrocyte, mHb,
pg
5 mM/l of glucose 43.92 ± 1.42 125.54 ± 1.45 73.60 ± 2.78 1.67 ± 0.19 52.66 ± 1.99
26.28 ± 0.99
10 mM/l of glucose 45.44 ± 0.78 161.11 ± 1.49* 97.46 ± 2.08* 2.14 ± 0.20 34.93 ± 0.74
15 mM/l of glucose 78.91 ± 2.42* 147.16 ± 4.50 154.82 ± 5.14* 1.96 ± 0.18 55.20 ± 1.84*
20 mM/l of glucose 59.16 ± 1.31* 245.03 ± 3.56*1 193.26 ± 5.23*1 3.26 ± 0.05* 69.42 ± 1.87*
*P< 0.01 as related to normoglycemia;
∆P< 0.01 as related to previous level of hyperglycemia.
FIGURE 1 | 3D model (A) and profile (B) of human erythrocytes in normoglycaemia.
Upon a 30-min incubation of the cells, an increase in the
glycosylation of hemoglobin occurred only when the glucose
concentration was 20 mM/l, whereas a small but reliable growth
in methemoglobin formation, increase in membrane-bound
form of hemoglobin and degree of glycosylation of proteins in
erythrocytic membranes has been previously observed when the
glucose level exceeded a two-fold level (10 mm/l) (Table 1).
The data obtained using the spectrometric measurements
were confirmed by Raman scattering (Table 2).
We found a reliable decrease in the relative content of
oxygenated hemoglobin, with an average of 2%. Moreover,
we obtained similar spectrophotometric percentages of
hemoglobin forms (Tables 1, 2). The conformational changes
observed indicate an increased ability of hemoglobin to bind
to ligands and the reliable occurrence of low hemoglobin
affinity to oxygen in the case of 20-mM/l hyperglycaemia,
at approximately 11%. Furthermore, there is a low intensity
of symmetric and asymmetric vibrations of pyrrole rings,
which indicated a less conformational mobility of the haeme
structures and an impairment of the effective binding of ligands
(Table 2).
At 15- and 20-mM/l glucose hyperglycaemia, we detected a
high level of lysophosphatidylcholine (LFH) in the erythrocyte
membrane, and the content of phosphatidylcholine (PFS) was
reliably low under in conditions of increasing amounts of
glucose, i.e., up to 10mM/l. In addition, we recorded a low level
of sphingomyelin (SM) and fractions of phosphatidylinositol
+ phosphatidylserine (PI + PS). Strong hyperglycaemia (20
mm/l) is characterized by a low content of all fractions with a
simultaneous increase of in LPC (Table 3).
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FIGURE 2 | 3D model (A) and profile (B) of human erythrocytes incubated in 10-mM/l glucose media.
FIGURE 3 | 3D model (A) and profile of human erythrocytes (B) incubated in 15-mM/l glucose media.
FIGURE 4 | 3D model (A) and profile of human erythrocytes (B) incubated in 20-mM/l glucose media.
The percentage of increased lysophosphatides under strong
20-mm/l hyperglycaemia was 160%. The SM level was 2 to
3 times lower, with PC–3 times; PI+PS–2.35%; and PEA–4
times. The low content of phospholipids and high content of
lysophosphatides indicated the activation of phospholipase A and
C, which was accompanied by loosening of the membrane and
higher ion permeability (Mills and Needham, 2005).
Analysis of the content of free fatty acids (FFA) and the
product of the reaction catalyzed by phospholipase C and
diacylglycerol (DAG) showed growth that was proportional to
the level of hyperglycaemia, and the percentage of growth with
20 mM/l hyperglycaemia is 133 and 182%, respectively (Table 4).
These results clearly demonstrate the activity of
phospholipase.
The normal correlation of phospholipid fractions pre-
determines the effective regulation of active and passive transport
of substances, the sensitivity of cells to the action of ligands,
and the activity of membrane-bound enzymatic systems. The
optimal operation of ion-carrying systems (Ca2+ and Na+, K+-
ATP-PS) is facilitated by stable PEA content. During severe
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hyperglycaemia (20mm/l), a sharp decrease in PEA content will
be accompanied by a defect in ion-carrying processes (Table 3).
Moreover, it will trigger a general change in the structure of
the membrane phospholipid bilayer, as PEA is a structural
phospholipid (Delaunay, 2002).
Importantly, the low content of PEA causes a disorder in
endoglobular homeostasis and inhibition of the antioxidant
activity of cells in (Afanasiev et al., 2007). The low content of
phospholipids with polyunsaturated fatty acids (PC, PI, PEA)
triggers defatting of membranes and a high correlation of
cholesterol/PL, which is accompanied by changes in physico-
chemical properties, namely, high microviscosity. These findings
indicate that hyperglycaemia is followed by a disruption in
membrane permeability.
In hyperglycaemia, human erythrocytes demonstrate a high
content of peptide components, which was specifically high
when the content of glucose in the incubation medium was
10 mm/l (Table 5). A further increase in the level (degree) of
hyperglycaemia was accompanied by an increased release of
protein compounds into the incubation medium due to higher
cell membrane permeability (Table 5).
Measurement of the proteolytic activity revealed interesting
patterns. The release of µ-calpain fractions and identification
of the average activity of the enzyme showed a decrease with
a parallel increase in the degree of hyperglycaemia, which was
statistically significant when the concentration of glucose reached
20 mM/l. A low activity of caspase 3 was detected, which
was also strongest under conditions of severe hyperglycaemia
(Table 6). Increased proteolytic activity can be detected only by
the identification of the overall trypsin-like activity of cytosol
with respect to the high content of peptides in the haemolysate,
without the isolation of enzymes and addition of third proteolytic
substrates (Table 6).
Laser interference microscopy showed distinct structural
changes of erythrocytes with increased concentrations of glucose
in the incubation medium (Table 7, Figures 1–4).
During normoglycaemia, erythrocytes appeared similar to
discocytes, with a normal distribution of hemoglobin inside the
cells. During hyperglycaemia, the estimated parameters were
high overall. In addition to the relative areas of the erythrocytes,
all indicators were high in conditions of 20-mm/l hyperglycaemia
(Table 7).
With a high content of glucose in the incubation medium,
echinocytes accumulated in the population of cells, and the
cell profile demonstrated visible outgrowths on the erythrocyte
surface. At up to 15-mm/l glucose, spherocytes appeared, and the
cells appeared more swollen (Figure 3). At 20-mm/l glucose, the
cells were slightly compressed compared with 15-mm/l glucose;
however, other changes became more robust (Table 7, Figure 4).
DISCUSSION
Disorder in the metabolic and functional state of human
erythrocyte membranes at a high concentration of glucose in
the incubation medium occurs primarily due to the general
activation of biochemical and physicochemical processes in
cells. The shift in the dissociation curve in the direction of
deoxygenation causes increased methemoglobin formation as
DOHb, which is less resistant to auto-oxidation compared
tooxyform (Zavodnik and Lapshina, 1996; Ivanov, 2001). The
gradual reduction of the conformational mobility of haeme
structures (Table 2) is most likely caused by the high degree of the
glycosylated protein component of hemoglobin, its permeability
in the membrane, followed by a gradual increase in membrane-
bound hemoglobin (Table 1).
The observed increase in the degree of glycosylation of
membrane proteins induces changes in the state of membrane
phospholipids. The change in protein-lipid interactions results in
the activation of membrane phospholipase, causing an increase
in LPC and DAG, and results in a high content of FFA in
erythrocytic membranes. Membrane permeability under these
conditions increases, and the peptide and protein compounds are
released into the incubation medium. Some reduction in their
release at 20-mm/l hyperglycaemia may be accounted for by the
low activity of µ-calpain and caspase 3 due to less affinity to the
glycosylated form of hemoglobin. However, their content in the
erythrocytes and incubation medium was higher compared to
normoglycaemia, most likely due to the continued high trypsin-
like activity of the cell cytosol.
Metabolic disorders and injury to the cell membrane
trigger morphological changes in erythrocytes. Previous
research findings have shown a gradual accumulation of
structurally damaged cells in the population. First, in 10-mM/l
hyperglycaemia, the number of echinocytes increases (reversible
morphological changes) and the phase volume and thickness of
the cells increases. Next, stomacytes and spherocytes appear in
the population. LIM microscopic results indicated strong cell
swelling. In 20-mm/l hyperglycaemia, the number of spherocytes
increased. Furthermore, the cells showed some shrinkage, but
the ratio of surface/volume values reached a critical level. Thus,
haemoglytic destruction is very likely.
The destruction of erythrocytes in the bloodstream in
hyperglycaemia will result in a chronic inflammation response,
which can damage the body’s blood vessels.
Changes in the erythrocytic membrane not only result in
morphological disorders of the whole erythrocyte, but they
can also consequently result in conformational changes in
hemoglobin as well as its oxygen-binding and oxygen-transport
function. The low content of oxyhemoglobin, weak symmetric
and asymmetric oscillations of pyrrole rings and increase in
hemoglobin affinity to ligands, including oxygen, has been
demonstrated.
CONCLUSION
Taken together, we demonstrate the significant risk of the
prolonged availability of high glucose concentrations in
plasma. Nonspecific glycosylation of membrane proteins
and erythrocytesin hemoglobin results in a weak affinity of
hemoglobin to oxygen and its loss by cells enroute to tissues in
the human body. Moreover, the resulting damage to membranes
and cell metabolism increase the probability of an accumulation
of functionally defective aging erythrocytes in the circulating
population. More rapid spherization of erythrocytes, in the
absence of physiological mechanisms of apoptosis, introduces
the possibility of necrotic cell death in the bloodstream, resulting
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in the gradual development of chronic states of hypoxia and
inflammation.
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